Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Apnea in Late Preterm and Term Infants
NCT02408328Phase 2Withdrawn
- Sponsor
- Boston Children's Hospital
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of caffeine in apnea of prematurity (AOP), sponsored by Boston Children's Hospital. Planned start Jun 2020; status: withdrawn.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT02408328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408328.